Sign in
CompletedNo phase

Effect of Spinal Manipulative Therapy Combined with Brace in Moderate-severe Grade Adolescent Idiopathic Scoliosis: a Randomized Controlled Trial

Key facts

Who runs it
The First Affiliated Hospital of Zhejiang Chinese Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
169 people enrolled
Started
1 Jan 2023
Ended
30 Jul 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • the spinal manipulative therapy combined brace
  • brace
Record updated
18 October 2024

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • 10-18 years old
  • Primary curve magnitude 20°-60° Cobb angle
  • Signing informed consent and cooperating with treatment and follow-ups

Who cannot take part

  • The subjects with neuromuscular, rheumatic, cardiovascular, pulmonary, congenital spine-related disorders
  • Psychiatric problems
  • A history of spinal surgery

Other criteria

  • The target population for this study was those with moderate-severe grade AIS who met the comprehensive inclusion criteria recommended by the Scoliosis Research Society (SRS) and the Society on Scoliosis Orthopedic and Rehabilitation Treatment (SOSORT)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Objective: To determine whether spinal manipulative therapy combined with brace is superior to a control of brace alone in improving spinal deformity and quality of life of moderate-severe grade AIS.

Read full original descriptionShow less

Design: It is a prospective randomized controlled study. Patients who met the inclusion criteria were randomly assigned to either the spinal manipulative therapy combined brace group (SMTB) or the Brace group. All participants were prescribed with a GBW brace and the spinal manipulative regimen was provided to the subjects in the SMBT group. Cobb angle, angle of trunk rotation (ATR), quality of life (SRS-22), progression rates and surgical rates of the subjects were measured at baseline to the 12-month follow-up.

The 2 groups in the trial

  • SMTB groupTreatment being tested

    subjects in SMTB group and Brace group were all prescribed a brace with reference to the 2016 SOSORT guidelines and received preliminary assessment for brace design and fabrication at their first visit . Subjects were requested to wear orthosis 23 hrs/d and 1 hr for personal hygiene and exercise activities . The subjects were treated for 12 months . In addition, interview for compliance was launched when the subjects came to the scoliosis clinic for follow-up visits. Besides bracing, the SMTB group was treated with spinal manipulative therapy . If discomfort occurs, we will stop the treatment immediately. Spinal manipulation is performed twice a week. Two doctors with 10 years of clinical experience will perform all examinations and manipulations. Intensive training was given to the physiotherapists in spinal manipulation. The doctors took the medical history of all participants and performed a clinical examination.

    Treatment: the spinal manipulative therapy combined brace

  • Brace groupExisting treatment, for comparison

    Upon enrollment, subjects in SMTB group and Brace group were all prescribed a brace with reference to the 2016 SOSORT guidelines and received preliminary assessment for brace design and fabrication at their first visit. Subjects were requested to wear orthosis 23 hrs/d and 1 hr for personal hygiene and exercise activities. The subjects were treated for 12 months. In addition, interview for compliance was launched when the subjects came to the scoliosis clinic for follow-up visits.

    Treatment: brace

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
18 October 2024